Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes.
Julia K MaderLeslie C LillyFelix AbererT PoettlerD JohnsM TrautmannJ L WarnerT R PieberPublished in: Diabetic medicine : a journal of the British Diabetic Association (2018)
Adults with Type 2 diabetes were safely transitioned from insulin injections to the PAQ and had significantly improved glycaemic control and treatment satisfaction with insulin therapy. (ClinicalTrials.gov identifiers: NCT02158078 & NCT02419859).